Content area

|
|

Hjertesvigtsbehandling til patienter med kronisk nedsat venstre ventrikel-funktion

Forfatter(e)
Hans Eiskjær Hjertesygdomme, Aarhus Universitetshospital

Ugeskr Læger 2018;180:V06180453
Reference: 
Ugeskr Læger 2018;180:V06180453
Blad nummer: 
Sidetal: 

Hans Eiskjær:

Treatment of heart failure in patients with reduced left-
ventricular ejection fraction

Ugeskr Læger 2018;180:V06180453

Treatment of heart failure with reduced ejection fraction has undergone an enormous development over the latest three decades resulting in lower mortality. Standard treatment now includes use of angiotensin-converting-enzyme (ACE)-inhibitors, beta blockers and mineralocorticoid receptor antagonists. Diuretics are still the cornerstone in the symptomatic treatment of fluid retention. Combined angiotensin II receptor blockade and neprilysin inhibition is a new treatment option instead of ACE-inhibition for selected patients. Cardiac resynchronisation therapy and prophylactic implantable cardiac defibrillators further reduce mortality.

Du skal være logget ind for at læse denne artikel
Log ind

Right side